Genomic Center for Infectious Diseases (GCID)
The J. Craig Venter Institute (JCVI) Genomic Center for Infectious Diseases (GCID) was established by the National Institute for Allergy and Infectious Diseases (NIAID) to develop basic knowledge of infectious disease biology through the application of DNA sequencing, genotyping and comparative genome analysis. The central theme of the JCVI GCID is the application of innovative genomics-based approaches to study pathogens and determinants of their virulence, drug-resistance, immune evasion and interactions with the host, and host microbiome to advance research in pathogenicity, drug-resistance, disease transmission and vaccine development. Projects will take advantage of cutting edge sequencing platform, and comparative approaches for analyzing the sequence of key pathogenic organisms and closely related species.
The GCID contract is a new award that continues a previous initiative of Genomic Sequencing Center for Infectious Diseases (GSCID), awarded in 2009 and Microbial Sequencing Center (MSC), awarded in 2003. The JCVI GCID is one of three such centers. The two other such centers are at the Broad Institute and the Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine.
Both data and new analytical tools generated by the GCID will be shared publicly to advance research in pathogenicity, drug resistance, disease transmission and vaccine development. Data generated from the sequencing and genotyping projects will be released to the scientific community in accordance with the NIAID's data and reagent sharing and release guidelines.
The JCVI was selected to participate in this grant because of our expertise in genome sequencing, annotation and analysis.
All Publications that use data generated and/or are supported by the Sequencing Center at JCVI should acknowledge the sponsor as below:
"Research reported in this publication was supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number U19AI110819. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
For all GCID related publication, acknowledge the sponsor as below:
This project has been funded in whole or part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under Award Number U19AI110819.
Pictures/Images present have been found on the following sources: